Here are relevant reports on : long-term-care-pharmacy-market
-
Cosmetic Products Market by Type (Skin, Hair, Sun, Oral, Fragrance, Color, Soap, Bath, Shower, Personal Hygiene), Distribution Channel (Supermarket, Pharmacy, Departmental, Specialty, Direct, Internet, Salon) & Geography - Global Trends & Forecasts to 2019
Cosmetic products are manufactured by using chemicals, minerals, and some natural ingredients. Technological advancement in the manufacturing of cosmetic products is one of the driving factors for the cosmetic products market. The economic development in the emerging countries has further increased the utilization of cosmetic products as consumers have more disposable income.
- Published: April 2014
- Price: $ 4950
- TOC Available:
-
Face Mask Market by Nature (Disposable, Reusable), Material Type, Type (Surgical, Respirator), End-Use, Distribution Channel (Pharmacy & Drug Stores, Supermarket & Hypermarket, Specialty Stores, E-commerce) and Region - Global Forecast to 2027
The face mask market is expected to grow from USD 25.1 billion in 2022 to USD 3.0 billion by 2027, at a compound annual growth rate (CAGR) of 34.5% during the forecast period.The key players 3M Company (US), Honeywell International Inc. (US), Kimberly-Clark Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Alpha Pro Tech, Ltd. (Canada), Ambu A/S (Denmark), Cantel Medical Corp. (US), Shanghai Dasheng Health Products Manufacture Co., Ltd (China), Medline Industries, Inc. (US), Mölnlycke Health Care AB (Sweden), Foss Performance Materials, LLC (US), Prestige Ameritech (US), Makrite (Taiwan), CNTUS-SUNGJIN Co., Ltd. (South Korea), and Irema Ireland (Ireland)
- Published: March 2022
- Price: $ 4950
- TOC Available:
-
Healthcare Dispensing Systems Market by Type (Automatic, Manual, Dispensing Component, Control System), Material (Reagent, Antibody, Powder), Application (Drug Delivery, Microfluidics), End User (Hospital, Pharmacy) & Region - Global Forecast to 2030
The global healthcare dispensing systems market, valued at US$4.36 billion in 2024, stood at US$4.61 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$6.27 billion by the end of the period. The market's accelerated growth trajectory is primarily driven by increasing demand for precision dispensing in pharmaceutical manufacturing, diagnostics, and medical device production.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
North American Healthcare IT Market by Solution (Provider, Payer (Clinical (EHR, PHM, PACS & VNA, Telehealth, RCM, CDSS), Nonclinical (Analytics, Pharmacy, Interoperability)), Service (Claim, Billing)), End User (Hospital, Payer) - Global Forecast to 2030
The global North American healthcare IT market, valued at US$202.12 billion in 2024, stood at US$229.05 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of US$439.09 billion by the end of the period. The growth of this market can be attributed to increasing awareness about digital health, government mandates, financial incentives for adopting healthcare IT solutions, and a shift toward value-based care.
- Published: June 2025
- Price: $ 6150
- TOC Available:
-
Medical Robots Market by Product & Service (Instruments & Accessories, Robotic Systems), Type (Surgical (Soft: General, Gynecological, Urological; Hard: Knee & Hip, Spine), Rehab, Radiosurgery, Hospital & Pharmacy), End User & Region - Global Forecasts to 2029
The global medical robots market, valued at US$13.8 billion in 2023, stood at US$16.0 billion in 2024 and is projected to advance at a resilient CAGR of 16.1% from 2024 to 2029, culminating in a forecasted valuation of US$33.8 billion by the end of the period. The growth of the medical robots market is mainly driven by the advancements in medical robotics technology, the increasing need for automation in healthcare, advancements in healthcare funding & infrastructure driven by an aging population, and rising chronic diseases, along with the growing need to minimize medication errors.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027
Veterinary pain management market growth is primed to transition from $1.8 billion in 2022 to $2.5 billion by 2027, showcasing a strong CAGR of 6.7%. Factors such as growth in companion animal adoption, the increasing number of veterinary practitioners and their rising income levels in developed economies, increasing consumption of meat & milk, the growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of this market.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region - Global Forecast to 2030
The global Artificial Intelligence (AI) in healthcare market, valued at US$14.92B in 2024, is forecasted to grow at a 38.6% CAGR, reaching US$21.66B by 2025 and US$110.61B by 2030. Market growth in the Asia Pacific can be attributed to the presence of a large and growing patient population, a gradual shift toward adopting technologies such as automation, data analytics, and cloud computing, and increasing spending on HCIT infrastructure.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) - Global forecast to 2030
The global Compounding Pharmacy market, valued at US$13.48 billion in 2024, stood at US$14.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$19.41 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030
The global real world evidence solutions market, valued at US$4.74 billion in 2024, stood at US$5.42 billion in 2025 and is projected to advance at a resilient CAGR of 14.8% from 2025 to 2030, culminating in a forecasted valuation of US$10.8 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counter, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient, Retail, ASC), Facility (Large, Mid) - Global Forecast to 2030
The global pharmacy automation market, valued at US$6.23B in 2023, is forecasted to grow at a 7.1% CAGR, reaching US$6.65B by 2024 and US$10.00B by 2030. The growth of the market is mainly fueled by the increasing incidence of chronic diseases, enhancing the need for effective and precise management of drugs. Moreover, the requirement of efficient pharmacy operations to boost the efficiency of the workflow and cut down medication mistakes is accelerating the usage of automation.
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
